Toothpaste product recalled for Current Good Manufacturing Practice deviations
Maximum Security Anticavity Gel Toothpaste is being recalled due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects tubes distributed to Delaware and North Carolina.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with CGMP deviations and no reported illnesses or injuries. Per the severity rubric, voluntary precautionary recalls without reported harm are classified as Moderate (Score 2).
Plain-English summary
Maximum Security Anticavity Gel Toothpaste (Sodium Fluoride 0.22%, Fresh Mint Flavor, 0.85 oz tubes) manufactured by KENIL HEALTHCARE PRIVATE LIMITED in India and distributed by Bob Barker Co. Inc. is subject to a recall due to Current Good Manufacturing Practice (CGMP) deviations.
The specific affected lots and expiration dates are: Lot B0008, B0009, B0017 (exp. 05/31/2026); Lot B0042, B0043, B0044 (exp. 06/30/2026); Lot B0049, B0050, B0051, B0054, B0058, B0059 (exp. 07/31/2026); and Lot B0061, B0062, B0063, B0064, B0065, B0068, B0069 (exp. 08/31/2026).
The affected product was distributed in Delaware and North Carolina. Consumers who have purchased affected products should discontinue use. This is an FDA Class II recall that was voluntarily initiated by the manufacturer on April 24, 2025, and terminated on February 19, 2026.
The recalled product
- Product
- Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 0.85 oz (24 g) Tube, Made in India, Dist. by Bob Barker Co. Inc. Fuquay-Varnia, NC 27526, NDC 53247-132-03
- Manufacturer
- KENIL HEALTHCARE PRIVATE LIMITED
- Category
- Drug — Toothpaste
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot B0008
- B0009
- B0017
- Exp Date: 05/31/2026
- Lot B0042
- B0043
- B0044
- Exp Date: 06/30/2026
- Lot B0049
- B0050
- B0051
- B0054
- B0058
- B0059
- Exp Date: 07/31/2026
- Lot B0061
- B0062
- B0063
- B0064
- B0065
Distribution
Distributed in 2 states:
- DE
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27